Herriot Tabuteau

Early Life and Education

Herriot Tabuteau was born in Haiti and immigrated to the United States at age nine. He grew up in New York City, attending Xavier High School. He went on to graduate from Wesleyan University with a degree in molecular biology and biochemistry. He earned his M.D. from Yale School of Medicine in 1994.

Rise to Success

Before founding Axsome Therapeutics in 2012, Dr. Tabuteau had a career in healthcare finance. He worked at Goldman Sachs and Banc of America Securities. He later became a partner at the healthcare-focused hedge fund Healthco/S.A.C. Capital. Axsome Therapeutics went public in 2015. In 2025, he was listed on Forbes as the first Haitian-born billionaire.

Key Business Strategies

Dr. Tabuteau's strategy involves developing innovative treatments for central nervous system disorders. His company has achieved FDA approvals for drugs like Auvelity (for major depressive disorder) and Sunosi (for narcolepsy). Axsome has also expanded its portfolio through acquisitions, such as Sunosi from Jazz Pharmaceuticals.

Philanthropy

While specific amounts are unavailable, Dr. Tabuteau's work is focused on improving lives and making a tangible difference for patients affected by neurological disorders.